相关实验视频

Updated: Jun 18, 2026

A Preclinical Murine Model of Hepatic Metastases
06:51

A Preclinical Murine Model of Hepatic Metastases

Published on: September 27, 2014

28.7K

结合KRAS抑制和免疫疗法在本土PDAC模型中产生持久的完整反应

Yonghong Liu1, Jincheng Han1, Wen-Hao Hsu1

  • 1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer discovery
|September 30, 2024
PubMed
概括

将KRAS抑制剂与免疫疗法剂结合起来,可以克服胰腺癌 (PDAC) 中的免疫抑制性瘤微环境. 这种方法在临床前模型中导致显著的瘤减少和延长存活时间.

更多相关视频

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

11.1K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.